LINC00857 and cancer: By simultaneous analysis of four databases (Sangerbox 3.0, ACLBI, StarBase V3.0 and Lnc2Cancer 3.0), we found that the expression levels of LINC00857 were markedly higher in eight cancers than in the adjacent normal tissues including HNSC, CHOL, COAD, KIRP, STAD, LIHC, PAAD and LUAD.